Review of literature: Does pharmacist’s interventions improve control and management of hypertension
- Autores: Muhammad Amer, Nisar Ur Rehman, Ur Rashid Nazir Saeed
- Localización: European journal of clinical pharmacy: atención farmacéutica, ISSN 2385-409X, Vol. 20, Nº. 3, 2018, págs. 7-7
- Idioma: inglés
- Títulos paralelos:
- Amer
- Texto completo no disponible (Saber más ...)
-
Resumen
Objective: Hypertension is an overwhelming worldwide challenge which positions third as a reason for disability-adjusted life-years. Several epidemiological studies have demonstrated that hypertension is an independent risk factor for stroke and coronary heart disease. The current review evaluates the contributions of pharmacists to the more positive, long-term prognosis of patients with hypertension through improvements in its control and management. A systematic literature search was conducted by the authors.
Method: The studies included in this systematic review were identified through a search of PubMed, Medline, Cochrane Library Databases, ERIC, EMBASE, PsychINFO and Dissertation. An initial search identified 34 published articles by using the above terms in searches of abstracts. Full texts of all articles were obtained and independently read in full by the authors in order to identify those papers which were suitable for inclusion in this review.
Results: In all the cases, it was reported that the intervention was successful in reducing blood pressure in patients with hypertension. Pharmacist interventions have also proven successful in improving patient lipid profiles, cardiovascular outcomes, body mass indexes, medication adherence, knowledge about hypertension, health related quality of life and in reducing other complications associated with the disease. It reported that the economic benets were also associated with a pharmacist’s management of hypertension.
Conclusion: Pharmacist integration into a healthcare team has been shown to be effective in improving a number of clinical, economic, and humanistic outcomes
